Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 18OTHER_GOV 3NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Hepatitis B 2Lymphoma, Non-Hodgkin 1Lymphoma 1Carcinoma, Hepatocellular 1Arthritis, Rheumatoid 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × entecavir × Clear all
NCT01907230 2019-03-13

Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
115 enrolled

Arthritis, Rheumatoid

NCT00926757 2013-05-29

HBVNHL

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed
80 enrolled
Lymphoid

Hepatitis B, Lymphoma, Lymphoma, Non-Hodgkin

NCT01018381 2009-11-23

Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection

The 108 Military Central Hospital

Phase NA Completed
130 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡